Back to search

Netherlands· NL-851cb6b21453

Flurazepam HCl Aurobindo 15 mg, capsules

A flurazepam product containing flurazepam monohydrochloride, registered in Netherlands by Aurobindo Pharma B.V.. The same ATC class is registered in 11 of our 19 countries.

ATC N05CD01

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedFlurazepam HCl Aurobindo 15 mg, capsu…ATCN05CD01REGISTER NO.NL-851cb6b21453PACKS LISTED1CHECKEDJuly 14, 2026

Where it is registered

Flurazepam is registered in 11 of 19 countries.

Countries holding a registration under ATC N05CD01 (flurazepam), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 5 of them publish a price we can compare per daily dose

Flurazepam · ATC N05CD01

11 / 19 countries

  • Belgiumprice
  • Canada
  • Germany
  • Ireland
  • Japan
  • Netherlands
  • Norwayprice
  • Spainprice
  • Switzerlandprice
  • United Kingdom
  • United Statesprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of flurazepam costs, country by country.

Normalised to the WHO defined daily dose (30 mg), the median price runs from $0.14 in Spain to $1.13 in Switzerland — a ×7.9 gap.

  • 2 markets with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown

Flurazepam · price per daily dose (30 mg)

USD · FX 28 Sept 2026

  • CH Switzerland$1.13
  • ES Spain$0.14
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)
Active substance
FLURAZEPAM MONOHYDROCHLORIDE
Manufacturer
Aurobindo Pharma B.V.
Country
Netherlands (NL)
ATC code
N05CD01
ATC class
Flurazepam
Defined daily dose
30 mg, O
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
July 14, 2026

Packs & prices · 1

  • cbg_meb_id
    21481=56480

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

209 interactions on record for flurazepam.

Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan

Flurazepam · interactions on record

209 records

  • 4 severe
  • 107 moderate
  • 22 minor
  • 32 info

Most severe, free to view

  • MorphineN02AA01severe
  • MorphinN07BC09severe
  • HydrocodoneR05DA03severe
  • CodeineR05DA04severe

44 more interactions with mechanism and management, from a commercially licensed source.

Sign in to check
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Flurazepam in 3 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All flurazepam products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

  • Germany · Dalmadorm
  • Spain · Dormodor
  • United Kingdom (Northern Ireland) · Dalmane
  • Croatia · Fluzepam
  • Ireland · Dalmane
  • Italy · Dalmadorm, Felison
  • Portugal · Dalmadorm
  • Slovenia · Fluzepam

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/bae075ee-b224-441d-8f0b-b4ff44596aef
GET /v1/drugs/bae075ee-b224-441d-8f0b-b4ff44596aef?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Capsule, hard",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h56480_smpc.pdf",
  "strength": null,
  "atc_label": "Flurazepam",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg21481",
  "excipients": [
    "BRILJANTZWART BN (E 151)",
    "CELLULOSE, MICROKRISTALLIJN (E 460(i))",
    "ERYTHROSINE (E 127)",
    "GELATINE (E 441)",
    "IJZEROXIDE ROOD  (E 172)",
    "IJZEROXIDE ZWART (E 172)",
    "LACTOSE 1-WATER",
    "LECITHINE, SOYA (E 322)",
    "MAGNESIUMSTEARAAT (E 470b)",
    "NATRIUMZETMEELGLYCOLAAT",
    "POVIDON K 90 (E 1201)",
    "RODE INKT",
    "SCHELLAK (E 904)",
    "SILICIUMDIOXIDE (E 551)",
    "SILICONEN ANTISCHUIM DC 1510",
    "TITAANDIOXIDE (E 171)"
  ],
  "substances": [
    "FLURAZEPAM MONOHYDROCHLORIDE"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h21481.pdf",
  "authorised_at": "1997/07/07",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "21481=56480",
  "additional_monitoring": "N"
}

See everything about flurazepam.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.